OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.

AdnaGen AG is a biotechnology company that develops molecular genetic diagnostic testing systems for the medical and clinical research laboratories. The company offers AdnaTest kits including reagents for immunomagnetic selection, mRNA isolation, and multiplex RT-PCR for tumor diagnostics. In addition, it focuses on genetic pre-disposition, pharmoco genetics, and non-invasive prenatal diagnostic systems for early detection, prevention, and monitoring of human diseases. The company was founded in 1999 and is headquartered in Langenhagen, Germany. As of February 23, 2006, AdnaGen AG is a subsidiary of OncoVista, Inc.

Hefei Zhongkepu Ruisheng Biomedical Technology Co., Ltd., established on 2015-07-16, Business scope includes research on biomedical engineering technology,to develop,transfer,consultation service,Biomedical Experimental Technology Services,Experimental technology consulting service and transfer;Biological experiment reagent,Development of Consumables for Biological Experiments,Sales;Drug and medical information consultation service;Self-operated and agent import and export business of various commodities and technologies(Except for those restricted or prohibited by the state);clinical body fluid,blood test;Clinical tissue and cell biology assays,Molecular genetics professional testing;Medical testing consultation;Medical Information Consultation;data collection;Big Data Services and Applications;Research and development of biomedical technology and software technology,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor immunity pathways. The company has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct pathways relevant to mounting an effective anti-tumor response. Tempest Therapeutics was established in 2011 and is headquartered in San Francisco, California.

Manufactures pharmaceuticals and diagnostic substances

Jiangyin Bent Samuelson Life Science Research Institute Co., Ltd., established on 2013-07-03, Business scope includes pharmaceutical,Medical Device Research,to develop,Technical Services,technology transfer;Healthcare Management Services;cosmetic,biochemical reagents,Peptide and protein pharmaceutical intermediates,disinfection products(The above items do not contain dangerous goods),hygiene products,Sales of Medical Devices;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Burning Rock Medical Laboratory Co., Ltd., established on 2014-03-18, Business scope includes manufacturing of information chemicals(Monitor Chemicals,Excluding hazardous chemicals);Medical Research and Experimental Development;Instrument wholesale;General Machinery Sales;Medical supplies and equipment retail(Does not contain drugs and medical devices);Machinery and Equipment Leasing;computer retail;software retail;Medical equipment rental service;Sales of electrical machinery and equipment;Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Special Equipment Sales;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Manufacturing of special chemicals(Monitor Chemicals,Excluding hazardous chemicals);Manufacturing of other non-hazardous basic chemical raw materials;Manufacturing of experimental analysis instruments;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;software development;Import and export(Excluding franchised products);Technology Import and Export;Operation of non-licensed medical devices;Clinical Laboratory Services;medical diagnosis,Monitoring and treatment equipment wholesale;medical diagnosis,Monitoring and treatment equipment retail;Monitor Chemical Manufacturing;medical diagnosis,Monitoring and treatment equipment manufacturing;Manufacturing of medical laboratory equipment and appliances;Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail);Licensed medical device business

Gold Label Medical Devices (Chengdu) Co., Ltd., established on 2020-07-15, Business scope includes licensed projects:Production of protective equipment for medical personnel(Class II medical device);Class III Medical Device Leasing;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of medical masks;Internet information service;Internet Information Service for Medical Devices;road freight transport(Does not contain dangerous goods);Production of hygiene products and single-use medical products;Class III medical device business;Disinfection equipment sales;Production of sterile equipment;Disinfectant production(Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Production of protective equipment for medical personnel(Ι class medical device);Sales of Class I Medical Devices;Class I Medical Device Leasing;Class II Medical Device Leasing;Wholesale of protective equipment for medical staff;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Development of Human Gene Diagnosis and Therapy Technology;New material technology promotion service;internet data service;Information Consulting Service(Not including licensing information consulting services);New material technology research and development;R&D and application of cell technology;Medical Mask Retail;Production of Class I Medical Devices;Technology Import and Export;Import and export;Certification Consulting;Information Technology Consulting Services;Sales of hygiene products and single-use medical products;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Probuno (Chongqing) Biotechnology Co., Ltd., established on 2020-03-13, Business scope includes licensed projects:Inspection and testing service,Internet hospital services relying on physical hospitals,medical service,Internet Information Service for Medical Devices,Occupational Health Technical Services,Safety Evaluation Business,Certification Services,Internet information service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development,Development of Human Gene Diagnosis and Therapy Technology,Biochemical product technology research and development,software development,Standardized service,Sales of Class I Medical Devices,Teaching equipment sales,Smart Instrument Sales,Instrument sales,Optical Instrument Sales,Experimental analysis instrument sales,Chemical product sales(No licensed chemical products),Retailing of computer software, hardware and auxiliary equipment,Office Supplies Sales,Human stem cell technology development and application,Remote Health Management Services,Ecological resource monitoring,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Harbin Tianyi Ecological Agricultural Products Co., Ltd., established on 2008-04-11, Business scope includes sales:Pre-packaged food(Contains refrigerated frozen food)(The food business license is valid until2021year7moon18day),fertilizer,Packaged Seeds No Longer Divided;chicken,duck farming;Agricultural Technology Development,consult,transfer,Promotion service;Catering Services;crop planting;Acquisition of agricultural and sideline products;Food production and operation;General cargo road transport;Agricultural Information Technology Training(Does not include vocational skills or vocational qualification training programs that need to be licensed and approved to operate).

CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France.

Beijing Daxiang Biotech Co., Ltd. is a Chinese company located in Beijing. The firm develops application for human organ chips. It was founded in 2018 by Yu Zhou, he has been the CEO since the company founding.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Jiangsu Province Hospital of Traditional Chinese Medicine is a Chinese private company located in Nanjing. The firm provides medical services.

Zero One Artificial Intelligence Technology Research Institute (Nanjing) Co., Ltd., established on 2020-04-30, Business scope includes licensed projects:medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Artificial intelligence basic software development;Artificial intelligence application software development;Medical Research and Experimental Development;software development;Software outsourcing service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Data processing and storage support services;Big data service;Information system integration service;Information system operation and maintenance services;Information Technology Consulting Services;Information Consulting Service(Not including licensing information consulting services);Manufacturing of computer software, hardware and peripheral equipment;Intelligent control system integration;Industrial Design Services;Professional Design Services;Retailing of computer software, hardware and auxiliary equipment;business management;Conference and Exhibition Services;brand management;electronics sales;Legal advice(Does not include law firm business);Non-residential real estate leases;tax service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Baoweishi Biotechnology Co., Ltd., established on 2017-05-31, Business scope includes biotechnology research and development;Class II Medical Devices,Three types of research and development,Production,Sales(See license for specific items);Engaged in technical consulting in the field of medical technology,technology development,software development,Technical Services,technology transfer,Equipment Repair,Business Management Consulting,market research,Self-operated and agent import and export business of various domestic commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.